Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy—Reply

Ganessan Kichenadasse; Ashley Hopkins; Michael Sorich

doi:10.1001/jamaoncol.2020.0643

Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy—Reply

Ganessan Kichenadasse, Ashley Hopkins, Michael Sorich

College of Medicine and Public Health

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Abstract

We thank Sanchez and Furberg for their thoughtful comments in response to our recent article in JAMA Oncology on the association between body mass index (BMI) and overall survival with immune checkpoint inhibitor therapy for patients with advanced non–small cell lung cancer.1 We agree that the association of body size with survival outcomes in patients with advanced cancer is complex and evolving.

Original language	English
Pages (from-to)	941-942
Number of pages	2
Journal	JAMA Oncology
Volume	6
Issue number	6
Early online date	23 Apr 2020
DOIs	https://doi.org/10.1001/jamaoncol.2020.0643
Publication status	Published - Jun 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2020.0643Licence: In Copyright

Cite this

@article{ea7e0891a6354797860e305fe7ff9c93,

title = "Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy—Reply",

abstract = "We thank Sanchez and Furberg for their thoughtful comments in response to our recent article in JAMA Oncology on the association between body mass index (BMI) and overall survival with immune checkpoint inhibitor therapy for patients with advanced non–small cell lung cancer.1 We agree that the association of body size with survival outcomes in patients with advanced cancer is complex and evolving.",

author = "Ganessan Kichenadasse and Ashley Hopkins and Michael Sorich",

year = "2020",

month = jun,

doi = "10.1001/jamaoncol.2020.0643",

language = "English",

volume = "6",

pages = "941--942",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "6",

}

TY - JOUR

T1 - Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy—Reply

AU - Kichenadasse, Ganessan

AU - Hopkins, Ashley

AU - Sorich, Michael

PY - 2020/6

Y1 - 2020/6

N2 - We thank Sanchez and Furberg for their thoughtful comments in response to our recent article in JAMA Oncology on the association between body mass index (BMI) and overall survival with immune checkpoint inhibitor therapy for patients with advanced non–small cell lung cancer.1 We agree that the association of body size with survival outcomes in patients with advanced cancer is complex and evolving.

AB - We thank Sanchez and Furberg for their thoughtful comments in response to our recent article in JAMA Oncology on the association between body mass index (BMI) and overall survival with immune checkpoint inhibitor therapy for patients with advanced non–small cell lung cancer.1 We agree that the association of body size with survival outcomes in patients with advanced cancer is complex and evolving.

UR - http://www.scopus.com/inward/record.url?scp=85084142957&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2020.0643

DO - 10.1001/jamaoncol.2020.0643

M3 - Letter

C2 - 32324194

AN - SCOPUS:85084142957

SN - 2374-2437

VL - 6

SP - 941

EP - 942

JO - JAMA Oncology

JF - JAMA Oncology

IS - 6

ER -

Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy—Reply

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this